Paul Murphy
Question:1851. Deputy Paul Murphy asked the Minister for Health if his attention has been drawn to the fact that in September 2020 the National Centre for Pharmacoeconomics refused reimbursement for the life-changing gene therapy luxturna unless cost effectiveness can be improved relative to existing treatments; if his attention has been further drawn to the fact that there are no existing treatments for inherited retinal disease (details supplied); if he will request that the National Centre for Pharmacoeconomics review its decision and include the drug in the list of drug treatments approved for reimbursement; and if he will make a statement on the matter. [19135/21]
View answer